Accordion Content
- December 24 Private Placement
- December 17 Advisory board appointment and option grant
- November 18 Garfield Hills Property assignment agreement
- November 12 Garfield Hills Project
- October 30 IR agreement with Spark Newswire Inc.
- October 20 work program and 2 IR agreements
- August 7 Dory Property payment
- July 23 Stock option grant
- July 21 private placement announced June 27 closes fully subscribed
- June 27 results of Annual General and Special Meeting, Private Placement & Stock Options
- June 23 Termination of Project 176 and Itza Property Option Agreement
- February 18 Private Placement closes
- February 4 Private Placement announced
- January 28 Stock Option cancellation
- January 28 Share Consolidation is Complete
- January 13 Share Consolidation
- January 10 Amendment to Property option agreements
- December 16 Update regarding AGM and Special Meeting
- November 29 AGM re-scheduled
- October 15 update Nunavut Exploration Program
- October 7 Stock Option Grant
- September 23 IR Agreement with i2i Marketing Group
- July 3 Recent Market Activity
- June 27 Uranium Properties work program commences
- June 18 Geological Exploration Program on 176 and Itza Uranium Properties in Nunavut
- June 13 Company engages Hillside Media
- June 5 Stock Option Grant
- May 21 Lexston has been upgraded to QB on OTC Markets Symbol LEXTF
- May 15 closing of Private Placement
- April 26 Private Placement
- April 16 Dory Project property payment
- February 21 Permitting for Nunavut Uranium Projects
- January 23 adding to land package in Nunavut
- January 11 Stock Option Grant
- January 10 Uranium Property Payment and Issuance of 1m SharesM
- November 27, 2023 Nunavut Uranium Properties (pdf)
- November 16, 2023 Frankfurt listing details (pdf)
- November 15, 2023 LOOKING TO ACQUIRE URANIUM ASSETS (pdf)
- November, 8, 2023 Results of AGSM (pdf)
- October 19, 2023 Change of Business and Change of Name (pdf)
- June 28, 2023 change of auditors (pdf)
- June 2, 2023 Filing of NI 43-101 technical Report (pdf)
- May 31, 2023 Amendment to property option (pdf)
- March 3, 2023 Rick Walker joins Board of Lexston (pdf)
- February 24, 2023 Update re Change of Business (pdf)
- January 18, 2023 Change of Business (pdf)
- October 17, 2022 Resignation of Director (pdf)
- October 6, 2022 correction to date for the Stock Option Grant (pdf)
- October 3, 2022 Stock Option grant (pdf)
- September 12, 2022 BOD addition (pdf)
- September 8, 2022 Resignation of Director (pdf)
- August 11, 2022 Results of Annual General and Special Meeting (pdf)
- July 4, 2022 Closing of the Private Placement (pdf)
- June 27, 2022 Private Placement increased (pdf)
- June 15, 2022 resignation of Philippe Henry as Director and CSO (pdf)
- June 9. 2022 Subsidiaries lay off staff (pdf)
- June 3, 2022 Cancellation of options (pdf)
- June 1, 2022 Private Placement (pdf)
- May 20, 2022 Share Consolidation (pdf)
- May 13, 2022 Share Consolidation (pdf)
- April 11, 2022 Allenii Project (pdf)
- March 25, 2022 appointment of CFO (pdf)
- Jan 31, 2022 Section 56 exemption (pdf)
- Jan 24, 2022 Egret-8SNP (pdf)
- Jan 19, 2022 Egret-NRCirap (pdf)
- Jan 14, 2022 Market Activity (pdf)
- Jan 12, 2022 MOU ALVARIUS (pdf)
- Jan 10 2022 MOU Panacea (pdf)
- Dec 15, 2021 DTC ELIGIBILITY (pdf)
- Nov 15, 2021 OTC listing (pdf)
- Nov 11, 2021 Lexston NR re STOCK OPTION GRANT (pdf)
- Sept 28, 2021 Psy (pdf)
- Sept 23, 2021 RESEARCH and DEVELOPMENT (pdf)
- Sept 20, 2021 ACQUISITION OF ZEN (pdf)
- July 13, 2021 Section 56 update (pdf)
- July 7, 2021 Psy PP (pdf)
- July 5, 2021 STOCK OPTION GRANT (pdf)
- June 30, 2021 BOD Graeme Staley (pdf)
- June 23, 2021 initial release (pdf)
- June 21 2021 CSE – New Listing – Lexston Life Sciences Corp (pdf)